MétaCan
Menu
Back to cohort
Record W4289766408 · doi:10.1016/j.ejca.2022.06.011

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

2022· article· en· W4289766408 on OpenAlexafffund
Isabelle Grootes, Renske Keeman, Fiona M. Blows, Roger L. Milne, Graham G. Giles, Anthony J. Swerdlow, Peter A. Fasching, Mustapha Abubakar, Irene L. Andrulis, Hoda Anton‐Culver, Matthias W. Beckmann, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Bernardo Bonanni, Ignacio Briceño, Barbara Burwinkel, Nicola J. Camp, Jose E. Castelao, Ji‐Yeob Choi, Christine L. Clarke, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Peter Devilee, Thilo Dörk, Alison M. Dunning, Miriam Dwek, Douglas F. Easton, Mikael Eriksson, Kristina Ernst, D. Gareth Evans, Jonine D. Figueroa, Visnja Fink, Giuseppe Floris, Stephen B. Fox, Marike Gabrielson, Manuela Gago-Domínguez, José Á. García-Sáenz, Anna González‐Neira, Lothar Haeberle, Christopher A. Haiman, Per Hall, Ute Hamann, Elaine F. Harkness, Mikael Hartman, Alexander Hein, Maartje J. Hooning, Ming‐Feng Hou, Sacha J. Howell, Hidemi Ito, Anna Jakubowska, Wolfgang Janni, Esther M. John, Audrey Jung, Daehee Kang, Vessela N. Kristensen, Ava Kwong, Diether Lambrechts, Jingmei Li, Jan Lubiński, Mehdi Manoochehri, Sara Margolin, Keitaro Matsuo, Nur Aishah Mohd Taib, Anna Marie Mulligan, Heli Nevanlinna, William G. Newman, Kenneth Offit, Ana Osório, Sue K. Park, Tjoung‐Won Park‐Simon, Alpa V. Patel, Nadège Presneau, Katri Pylkäs, Brigitte Rack, Paolo Radice, Gad Rennert, Atocha Romero, Emmanouil Saloustros, Elinor J. Sawyer, Andreas Schneeweiß, Fabienne Schochter, Minouk J. Schoemaker, Chen‐Yang Shen, Rana Shibli, Hans‐Peter Sinn, William Tapper, Essa Tawfiq, Soo‐Hwang Teo, Lauren R. Teras, Diana Torres, Celine M. Vachon, Carolien H. M. van Deurzen, Camilla Wendt, Justin A. Williams, Robert Winqvist, Mark Elwood, Marjanka K. Schmidt, Montserrat García‐Closas, Paul D.P. Pharoah

Bibliographic record

VenueEuropean Journal of Cancer · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsUniversity Health NetworkLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersServicio Gallego de SaludInstitute of Biomedical Sciences, Academia SinicaNational Medical Research CouncilCancer Council TasmaniaCancer Council VictoriaMedical Research CouncilCanadian Institutes of Health ResearchProgramme Grants for Applied ResearchManchester Biomedical Research CentreU.S. ArmyImperial Experimental Cancer Medicine CentreNational Institutes of HealthNational University Health SystemMinistero dello Sviluppo EconomicoNational Health and Medical Research CouncilOulun YliopistoDeutsche KrebshilfeNorges ForskningsrådStockholms Läns LandstingKarolinska InstitutetCenters for Disease Control and PreventionLeids Universitair Medisch CentrumNational Research Foundation of KoreaKorea Health Industry Development InstituteMinistry of Education, Science and TechnologyBundesministerium für Bildung und ForschungMinistry of Education, Culture, Sports, Science and TechnologyMinisterio de Economía y CompetitividadAcademy of FinlandNational Breast Cancer FoundationMinistry of Health, Labour and WelfareWellcome TrustMemorial Sloan-Kettering Cancer CenterFondation du cancer du sein du QuébecMark Foundation For Cancer ResearchCancer AustraliaHuntsman Cancer InstituteKWF KankerbestrijdingNational University of SingaporeCancer Research UKDeutsches KrebsforschungszentrumNational Institute for Health and Care ResearchNational Research FoundationNational Research Foundation SingaporeBreast Cancer Research FoundationUniversity of CambridgeHuntsman Cancer FoundationCancer Council NSWSusan G. Komen for the CureTaiwan BiobankKreftforeningenAcademia SinicaHORIZON EUROPE Framework ProgrammeAssociazione Italiana per la Ricerca sul CancroMinistère du Développement Économique, de l’Innovation et de l’ExportationLon V. Smith FoundationAgency for Science, Technology and ResearchKerry Group Kuok FoundationNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchBreast Cancer CampaignUniversity of UtahCancer Council South AustraliaFonds Wetenschappelijk OnderzoekNational University Cancer Institute, SingaporeCancerfondenNational Cancer InstituteCancer Institute NSWIntermountain HealthcareJapan Agency for Medical Research and DevelopmentMedical Research and Materiel CommandMinistry of Health -SingaporeEuropean CommissionU.S. Department of Health and Human Services
KeywordsProgesterone receptorOestrogen receptorExpression (computer science)OncologyInternal medicineMedicineBiologyBreast cancerComputer scienceEstrogen receptorCancer

Abstract

fetched live from OpenAlex

Background Predict Breast (www.predict.nhs.uk) is an online prognostication and treatment benefit tool for early invasive breast cancer. The aim of this study was to incorporate the prognostic effect of progesterone receptor (PR) status into a new version of PREDICT and to compare its performance to the current version (2.2). Method The prognostic effect of PR status was based on the analysis of data from 45,088 European patients with breast cancer from 49 studies in the Breast Cancer Association Consortium. Cox proportional hazard models were used to estimate the hazard ratio for PR status. Data from a New Zealand study of 11,365 patients with early invasive breast cancer were used for external validation. Model calibration and discrimination were used to test the model performance. Results Having a PR-positive tumour was associated with a 23% and 28% lower risk of dying from breast cancer for women with oestrogen receptor (ER)-negative and ER-positive breast cancer, respectively. The area under the ROC curve increased with the addition of PR status from 0.807 to 0.809 for patients with ER-negative tumours ( p = 0.023) and from 0.898 to 0.902 for patients with ER-positive tumours ( p = 2.3 × 10 −6 ) in the New Zealand cohort. Model calibration was modest with 940 observed deaths compared to 1151 predicted. Conclusion The inclusion of the prognostic effect of PR status to PREDICT Breast has led to an improvement of model performance and more accurate absolute treatment benefit predictions for individual patients. Further studies should determine whether the baseline hazard function requires recalibration.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.242
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Journal of CancerSame topicBreast Cancer Treatment StudiesFrench-language works237,207